Germany
Japan
United Kingdom
China
Anti-Complement C5 Reference Antibody (ravulizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Macaque, Cynomolgus |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadAnti-Complement C5 Reference Antibody (eculizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Anti-Complement C5 Reference Antibody (tesidolumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Anti-Complement C5 Reference Antibody (crovalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-Complement C5 Reference Antibody (lendalizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-Complement C5 Reference Antibody (pozelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-Complement C5 Reference Antibody (vilobelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- COMPLEMENT C5
Expression Hosts
- CHO